These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


761 related items for PubMed ID: 23348153

  • 21. Thermoanalytical and Fourier transform infrared spectral curve-fitting techniques used to investigate the amorphous indomethacin formation and its physical stability in Indomethacin-Soluplus® solid dispersions.
    Lin SY, Lin HL, Chi YT, Huang YT, Kao CY, Hsieh WH.
    Int J Pharm; 2015 Dec 30; 496(2):457-65. PubMed ID: 26481469
    [Abstract] [Full Text] [Related]

  • 22. Characterization and stability of solid dispersions based on PEG/polymer blends.
    Bley H, Fussnegger B, Bodmeier R.
    Int J Pharm; 2010 May 10; 390(2):165-73. PubMed ID: 20132875
    [Abstract] [Full Text] [Related]

  • 23. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
    Zhang K, Yu H, Luo Q, Yang S, Lin X, Zhang Y, Tian B, Tang X.
    Eur J Pharm Biopharm; 2013 Nov 10; 85(3 Pt B):1285-92. PubMed ID: 23562534
    [Abstract] [Full Text] [Related]

  • 24. The development of carbamazepine-succinic acid cocrystal tablet formulations with improved in vitro and in vivo performance.
    Ullah M, Hussain I, Sun CC.
    Drug Dev Ind Pharm; 2016 Nov 10; 42(6):969-76. PubMed ID: 26460090
    [Abstract] [Full Text] [Related]

  • 25. Use of the Flory-Huggins theory to predict the solubility of nifedipine and sulfamethoxazole in the triblock, graft copolymer Soluplus.
    Altamimi MA, Neau SH.
    Drug Dev Ind Pharm; 2016 Mar 10; 42(3):446-455. PubMed ID: 26266965
    [Abstract] [Full Text] [Related]

  • 26. Investigation of polymeric excipients for dutasteride solid dispersion and its physicochemical characterization.
    Kim NA, Choi du H, Lim JY, Kim KH, Lim DG, Lee E, Park ES, Jeong SH.
    Arch Pharm Res; 2014 Feb 10; 37(2):214-24. PubMed ID: 23775474
    [Abstract] [Full Text] [Related]

  • 27. Investigation of a suitable in vitro dissolution test for itraconazole-based solid dispersions.
    Thiry J, Broze G, Pestieau A, Tatton AS, Baumans F, Damblon C, Krier F, Evrard B.
    Eur J Pharm Sci; 2016 Mar 31; 85():94-105. PubMed ID: 26850682
    [Abstract] [Full Text] [Related]

  • 28. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
    Potter C, Tian Y, Walker G, McCoy C, Hornsby P, Donnelly C, Jones DS, Andrews GP.
    Mol Pharm; 2015 May 04; 12(5):1377-90. PubMed ID: 25730138
    [Abstract] [Full Text] [Related]

  • 29. Effect of tablet structure on controlled release from supersaturating solid dispersions containing glyceryl behenate.
    Keen JM, Hughey JR, Bennett RC, Jannin V, Rosiaux Y, Marchaud D, McGinity JW.
    Mol Pharm; 2015 Jan 05; 12(1):120-6. PubMed ID: 25347621
    [Abstract] [Full Text] [Related]

  • 30. Improving Dissolution Rate of Carbamazepine-Glutaric Acid Cocrystal Through Solubilization by Excess Coformer.
    Yamashita H, Sun CC.
    Pharm Res; 2017 Dec 29; 35(1):4. PubMed ID: 29288433
    [Abstract] [Full Text] [Related]

  • 31. Molecular interaction between glimepiride and Soluplus®-PEG 4000 hybrid based solid dispersions: Characterisation and anti-diabetic studies.
    Reginald-Opara JN, Attama A, Ofokansi K, Umeyor C, Kenechukwu F.
    Int J Pharm; 2015 Dec 30; 496(2):741-50. PubMed ID: 26581773
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The Synergetic Effects of Nonpolar and Polar Protic Solvents on the Properties of Felodipine and Soluplus in Solutions, Casting Films, and Spray-Dried Solid Dispersions.
    Chen Y, Huang W, Chen J, Wang H, Zhang S, Xiong S.
    J Pharm Sci; 2018 Jun 30; 107(6):1615-1623. PubMed ID: 29454624
    [Abstract] [Full Text] [Related]

  • 36. Investigation of drug-excipient interactions in lapatinib amorphous solid dispersions using solid-state NMR spectroscopy.
    Song Y, Yang X, Chen X, Nie H, Byrn S, Lubach JW.
    Mol Pharm; 2015 Mar 02; 12(3):857-66. PubMed ID: 25585133
    [Abstract] [Full Text] [Related]

  • 37. The influence of drug physical state on the dissolution enhancement of solid dispersions prepared via hot-melt extrusion: a case study using olanzapine.
    Pina MF, Zhao M, Pinto JF, Sousa JJ, Craig DQ.
    J Pharm Sci; 2014 Apr 02; 103(4):1214-23. PubMed ID: 24765654
    [Abstract] [Full Text] [Related]

  • 38. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.
    Al-Hamidi H, Edwards AA, Mohammad MA, Nokhodchi A.
    Colloids Surf B Biointerfaces; 2010 Mar 01; 76(1):170-8. PubMed ID: 19945828
    [Abstract] [Full Text] [Related]

  • 39. A (polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer)-dispersed sustained-release tablet for imperialine to simultaneously prolong the drug release and improve the oral bioavailability.
    Lin Q, Fu Y, Li J, Qu M, Deng L, Gong T, Zhang Z.
    Eur J Pharm Sci; 2015 Nov 15; 79():44-52. PubMed ID: 26349052
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 39.